Evidence-based dry-eye therapies for clinical use

CPD
1
8 October 2021
Volume 22, Issue 3

This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.

Domains covered

Professionalism Clinical practice Specialty CPD (IP)

Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Join the College today

Related further reading

Care after cataract: drug regimens

For optometrists working in the evolving area of cataract care, it is important to have an understanding of the different drug regimens available. Kathy Oxtoby reports.

Cataract

Drusen: the hallmark of AMD

Drusen can be a significant finding, but they aren’t always a harbinger of doom. With new approaches on the horizon, asks Kaye McIntosh, what should optometrists do when drusen are found?

AMD

Docet webinar: Dementia and Optometry - Research and Practice

This live webinar by Dr Rakhee Shah and Mr Simon Raw provides up-to-date guidance and research for adapting an eye examination to suit the needs of a patient with dementia.

Dementia